The Registry of Toxic Effects of Chemical Substances
Formamide, N,N - dimethyl - |
UPDATE: May 2005 | MW: 73.11 | MF: C3H7NO |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
100 mg rinse
|
severe
|
DCTODJ 9,147,1986
|
eye | rabbit
1,00% rinse
|
severe
|
CRTXB2 31,139,2001
|
skin | human
1,00%/24 hour
|
mild
|
BJIMAG 13,51,1956
|
skin | woman
0.1%
|
|
CRTXB2 31,139,2001
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
inhalation | human
12,300 µg/m3/1 year
|
ZHYGAM 31,366,1985
|
cytogenetic analysis
|
human
lymphocyte
|
100 nmol/L
|
CHPUA4 31,548,1981
|
cytogenetic analysis
|
intraperitoneal | mouse
40 µmol/kg
|
CHPUA4 31,548,1981
|
dominant lethal test
|
inhalation | rat
10,700 µg/m3
|
TPKVAL 15,21,1979
|
DNA repair
|
Saccharomyes cerevisiae
|
300 mg/L
|
PMRSDJ 1,502,1981
|
host-mediated assay
|
mouse
| Salmonella typhimurium
4,250 µg/kg
|
CHPUA4 31,548,1981
|
mutation in microorganisms
|
Salmonella typhimurium
|
600 µg/plate (-enzymatic activation step)
|
PMRSDJ 1,343,1981
|
micronucleus test
|
intraperitoneal | mouse
500 µg/kg/24 hour
|
DOYADI 8,27,1987
|
micronucleus test
|
intraperitoneal | mouse
1 mg/kg
|
CRTXB2 31,139,2001
|
micronucleus test
|
intraperitoneal | mouse
3 mg/kg/3 day- intermittent
|
CRTXB2 31,139,2001
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
5 gm/L
|
EMMUEG 11,91,1988
|
sex chromosome loss and nondisjunction
|
Saccharomyes cerevisiae
|
25 mg/L
|
PMRSDJ 1,468,1981
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 200 ppm/6 hour (13 week prior to copulation)
|
Reproductive: Other effects on female | Endocrine: Effect on menstrual cycle
NTPTR* NIH-93-3345
|
inhalation | rat
lowest published toxic concentration: 800 ppm/6 hour (13 week prior to copulation)
|
Reproductive: Other effects on female | Endocrine: Effect on menstrual cycle
NTPTR* NIH-93-3345
|
inhalation | rat
lowest published toxic concentration: 50 ppm/6 hour (13 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
NTPTR* NIH-93-3345
|
inhalation | rat
lowest published toxic concentration: 4 mg/m3/4 hour (1-19 day pregnant)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death
TPKVAL 14,32,1975
|
inhalation | rat
lowest published toxic concentration: 600 mg/m3/24 hour (1-19 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
TPKVAL 13,75,1973
|
inhalation | rat
lowest published toxic concentration: 287 ppm/6 hour (0-19 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
FCTOD7 29,,193,1991
|
inhalation | rat
lowest published toxic concentration: 300 ppm/6 hour (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
DCTODJ 15,1,1992
|
inhalation | rabbit
lowest published toxic concentration: 450 ppm/6 hour (7-19 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Body wall Reproductive: Specific developmental abnormalities: Musculoskeletal system
FCTOD7 29,193,1991
|
inhalation | rabbit
lowest published toxic concentration: 450 ppm/8 hour (7-19 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Gastrointestinal system
NTIS** OTS0535254
|
intraperitoneal | mouse
lowest published toxic dose: 2,100 mg/kg (11 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
DEGEA3 30,455,1975
|
intraperitoneal | mouse
lowest published toxic dose: 15,120 mg/kg (1-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Other developmental abnormalities
DEGEA3 30,455,1975
|
oral | mouse
lowest published toxic dose: 1,820 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
FCTOD7 29,193,1991
|
oral | rat
lowest published toxic dose: 5,330 µL/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
NTIS** OTS0521149
|
oral | rat
lowest published toxic dose: 5,030 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
FCTOD7 29,193,1991
|
oral | rat
lowest published toxic dose: 1,500 mg/kg (6-20 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
FAATDF 39,33,1997
|
oral | rat
lowest published toxic dose: 3,000 µg/kg (6-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
FAATDF 39,33,1997
|
oral | rabbit
lowest published toxic dose: 2,600 mg/kg (6-18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Specific developmental abnormalities: Body wall Reproductive: Specific developmental abnormalities: Musculoskeletal system
ARZNAD 30,1557,1980
|
oral | rabbit
lowest published toxic dose: 2,600 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
ARZNAD 30,1557,1980
|
skin | rat
lowest published toxic dose: 3,600 mg/kg (11-13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
TXAPA9 41,35,1977
|
skin | rat
lowest published toxic dose: 7,552 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Other effects to embryo or fetus
FCTOD7 29,193,1991
|
skin | rat
lowest published toxic dose: 20 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
JJATDK 10,333,1990
|
skin | rat
lowest published toxic dose: 20 gm/kg (1-20 day pregnant)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on newborn: Delayed effects
JJATDK 10,333,1990
|
skin | rabbit
lowest published toxic dose: 5,200 mg/kg (6-18 day pregnant)
|
Reproductive: Other effects to embryo or fetus
|
FCTOD7 29,193,1991
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lethal concentration (50 percent kill): 9,400 mg/m3/2 hour
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Muscle weakness Lung, Thorax, or Respiration: Dyspnea
TPKVAL 1,54,1961
|
inhalation | rat
lowest published lethal concentration: 5,000 ppm/6 hour
|
N/R
|
USXXAM #5122301
|
inhalation | rat
lethal concentration (50 percent kill): 3,421 ppm/1 hour
|
N/R
|
CRTXB2 31,139,2001
|
inhalation | rat
lethal concentration (50 percent kill): 3,421 ppm/3 hour
|
N/R
|
CRTXB2 31,139,2001
|
inhalation | rat
lethal concentration (50 percent kill): 1,948 ppm/4 hour
|
N/R
|
CRTXB2 31,139,2001
|
intramuscular | mouse
lethal dose (50 percent kill): 3,900 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
intraperitoneal | cat
lethal dose (50 percent kill): 500 mg/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Changes in cell count (unspecified)
BJIMAG 13,51,1956
|
intraperitoneal | guinea pig
lowest published lethal dose: 4 gm/kg
|
Liver: Fatty liver degeneration
|
AIHAAP 35,21,1974
|
intraperitoneal | mouse
lethal dose (50 percent kill): 650 mg/kg
|
N/R
|
CNCRA6 30,9,1963
|
intraperitoneal | rat
lethal dose (50 percent kill): 1,400 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Muscle weakness Nutritional and Gross Metabolic: Weight loss or decreased weight gain
BJIMAG 13,51,1956
|
intraperitoneal | rat
lethal dose (50 percent kill): 4 gm/kg
|
N/R
|
CRTXB2 31,139,2001
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 1 gm/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Changes in cell count (unspecified)
BJIMAG 13,51,1956
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 1 gm/kg
|
N/R
|
CRTXB2 31,139,2001
|
intravenous | dog
lethal dose (50 percent kill): 470 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
intravenous | guinea pig
lethal dose (50 percent kill): 1,050 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
intravenous | mouse
lethal dose (50 percent kill): 2,500 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
intravenous | rat
lethal dose (50 percent kill): 2 gm/kg
|
N/R
|
ZEKBAI 69,103,1967
|
intravenous | rabbit
lethal dose (50 percent kill): 1,800 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
oral | mouse
lethal dose (50 percent kill): 2,900 mg/kg
|
N/R
|
NTIS** OTS0521148
|
oral | rat
lethal dose (50 percent kill): 2,000 mg/kg
|
N/R
|
CBINA8 148,1,2004
|
oral | rabbit
lethal dose (50 percent kill): 5 gm/kg
|
N/R
|
NTIS** OTS0520699
|
subcutaneous | mouse
lethal dose (50 percent kill): 4,500 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
subcutaneous | rat
lethal dose (50 percent kill): 3,800 mg/kg
|
N/R
|
ARZNAD 15,618,1965
|
skin | rat
lethal dose : >3,160 mg/kg
|
N/R
|
NTIS** OTS0516779
|
skin | rat
lethal dose (50 percent kill): >3.2 gm/kg
|
N/R
|
CRTXB2 31,139,2001
|
skin | rabbit
lethal dose (50 percent kill): 4,720 mg/kg
|
N/R
|
AIHAAP 30,470,1969
|
unreported route | rat
lethal dose (50 percent kill): >3 gm/kg
|
N/R
|
ARZNAD 18,645,1968
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 800 ppm/6 hour/13 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in bladder weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NTPTR* NIH-93-3345
|
inhalation | mouse
lowest published toxic concentration: 50 ppm/13 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Changes in kidney weight Endocrine: Changes in thymus weight
TOSCF2 72,347,2003
|
inhalation | mouse
lowest published toxic concentration: 400 ppm/13 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Kidney, Ureter, and Bladder: Changes in kidney weight Endocrine: Changes in thymus weight
TOSCF2 72,347,2003
|
inhalation | rat
lowest published toxic concentration: 400 ppm/6 hour/13 week- intermittent
|
Liver: Changes in liver weight | Blood: Changes in erythrocyte (RBC) count Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
NTPTR* NIH-93-3345
|
inhalation | rat
lowest published toxic concentration: 300 mg/m3/4 hour/26 week- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Behavioral: Altered sleep time (including change in righting reflex)
GISAAA 23(5),31,1958
|
inhalation | rat
lowest published toxic concentration: 500 µg/m3/24 hour/60 day- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
GISAAA 27(4),3,1962
|
inhalation | rat
lowest published toxic concentration: 2,523 ppm/6 hour/5 day- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
DCTODJ 9,147,1986
|
inhalation | rat
lowest published toxic concentration: 50 ppm/13 week- intermittent
|
Liver: Changes in liver weight
|
TOSCF2 72,347,2003
|
inhalation | rat
lowest published toxic concentration: 200 ppm/4 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases
|
TOSCF2 72,347,2003
|
inhalation | rat
lowest published toxic concentration: 400 ppm/13 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TOSCF2 72,347,2003
|
oral | rat
lowest published toxic dose: 9 mL/kg/12 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Liver: Changes in liver weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
APJAAG 37,1879,1987
|
oral | rat
lowest published toxic dose: 13 gm/kg/15 week- continuous
|
Behavioral: Food intake (animal) | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOXID9 3,128,1983
|
oral | rat
lowest published toxic dose: 5,400 mg/kg/90 day- continuous
|
Liver: Changes in liver weight | Blood: Changes in erythrocyte (RBC) count Blood: Changes in leukocyte (WBC) count
DCTODJ 9,147,1986
|
oral | rat
lowest published toxic dose: 4,500 mg/kg/10 day- continuous
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Nutritional and Gross Metabolic: Other changes
NTIS** OTS0572893
|
skin | rabbit
lowest published toxic dose: 18 gm/kg/2 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
DCTODJ 9,147,1986
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 10 ppm (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not Classifiable as a Human Carcinogen
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 47,171,1989
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 47,171,1989
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 71,545,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal No Evidence
|
IMEMDT 71,545,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 71,545,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,21,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 10 ppm (30 mg/m3) (skin)
|
DTLVS* 3,90,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 10 ppm (30 mg/m3) (skin)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 10 ppm (30 mg/m3) (skin)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 10 ppm (30 mg/m3) (skin)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 10 ppm (30 mg/m3) (skin)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
10 ppm (30 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 10 ppm (30 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 10 ppm (30 mg/m3), short term exposure limit 20 ppm (60 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 10 ppm (30 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 20 ppm (60 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - HUNGARY
|
time-weighted average 10 mg/m3, short term exposure limit 20 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 15 mg/m3, Skin, 2003
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 10 mg/m3, MAC(short term exposure limit) 60 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 10 ppm, short term exposure limit 10 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 10 ppm (30 mg/m3), KTV 15 ppm (45 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 10 ppm (30 mg/m3), KZG- week 20 ppm (60 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 10 ppm (30 mg/m3), short term exposure limit 20 ppm, Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not Classifiable as a Human Carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not Classifiable as a Human Carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO DIMETHYLFORMAMIDE-air
|
10 hour time-weighted average 10 ppm (Sk)
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 26560; | Number of Industries 64; Total Number of Facilities 3,115; Number of Occupations 71; Total Number of Employees Exposed 69,191
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 26560; |
Number of Industries 85; Total Number of Facilities 6,209; Number of Occupations 93; Total Number of Employees Exposed 124,683; Total Number of Female Employees Exposed 16,011 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA GENETOX PROGRAM 1988, Negative: SHE-clonal assay; Sperm morphology-mouse
|
EPA GENETOX PROGRAM 1988, Negative: In vitro UDS in rat liver
|
EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a solvent for liquids and gases and as a gasoline additive
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Dimethylformamide, 2004
|
NTP Toxicity studies, RPT# TOX-22, October 2000
|
OSHA ANALYTICAL METHOD #ID-66
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
APJAAG
|
Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo
International, Tokyo 101-31, Japan) V.1- 1951-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
BJIMAG
|
British Journal of Industrial Medicine. (British Medical Journal, Box 560B, Kennebunkport, ME
04046) V.1- 1944-
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CHPUA4
|
Chemicky Prumysl. Chemical Industry. (SNTL-Statni Nakladatelstvi Technicke Literatury,
Spalena 51, 113 02 Prague 1, Czechoslovakia) V.1- 1951-
|
CNCRA6
|
Cancer Chemotherapy Reports. (Bethesda, MD) V.1-52, 1959-68. For publisher information, see
CTRRDO.
|
CRTXB2
|
CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton,
FL 33431) V.1- 1971-
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DEGEA3
|
Deutsche Gesundheitswesen. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin
DDR-1020, Ger. Dem. Rep.) V.1- 1946-
|
DOYADI
|
Dongwuxue Yanjiu. Zoological Research. (China International Book Trading Corp., POB 2820,
Beijing, Peop. Rep. China) V.1- 1980-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
PMRSDJ
|
Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1981-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPKVAL
|
Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial
Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow,
USSR) No.1- 1961-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
USXXAM
|
United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
|
ZEKBAI
|
Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher
information, see JCROD7.
|
ZHYGAM
|
Zeitschrift fuer die Gesamte Hygiene und Ihre Grenzgebiete. (VEB Verlag Volk und Gesundheit,
Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1955-
|
|